1 false false false false false false false false false false true false false false false false true No description of principal activity 2023-04-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 11453792 2023-04-01 2024-03-31 11453792 2024-03-31 11453792 2023-03-31 11453792 2022-04-01 2023-03-31 11453792 2023-03-31 11453792 2022-03-31 11453792 bus:Director1 2023-04-01 2024-03-31 11453792 core:WithinOneYear 2024-03-31 11453792 core:WithinOneYear 2023-03-31 11453792 bus:Micro-entities 2023-04-01 2024-03-31 11453792 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 11453792 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 11453792 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 11453792 bus:FullAccounts 2023-04-01 2024-03-31
COMPANY REGISTRATION NUMBER: 11453792
DR Nasr Healthcare Limited
Filleted Unaudited Financial Statements
31 March 2024
DR Nasr Healthcare Limited
Statement of Financial Position
31 March 2024
2024
2023
£
£
Current assets
202,504
151,543
Prepayments and accrued income
2,728
1,980
---------
---------
205,232
153,523
Creditors: amounts falling due within one year
39,666
17,390
---------
---------
Net current assets
165,566
136,133
---------
---------
Total assets less current liabilities
165,566
136,133
Accruals and deferred income
1,714
1,646
---------
---------
163,852
134,487
---------
---------
Capital and reserves
163,852
134,487
---------
---------
Notes to the financial statements
1. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2023: 1 ).
2. Director's advances, credits and guarantees
The director made loans to the company. The loans are interest free and repayable on demand. The balance outstanding as at 31st March 2024 £5,337 (2023 £4,945).
For the year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 28 August 2024 , and are signed on behalf of the board by:
Dr A. Nasr
Director
Company registration number: 11453792
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 60 Foxes Meadow, Birmingham, West Midlands, B30 1BQ.